Disease Info Card

Olfactory Neuroblastoma

Information about Olfactory Neuroblastoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Olfactory Neuroblastoma

Most recent studies have shown that Olfactory Neuroblastoma shares some biological mechanisms with adenocarcinoma, anaplastic-carcinoma, brain-neoplasms, carcinoma, ewings-sarcoma-primitive-neuroectodermal-tumor-(pnet), lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, melanoma, neoplasm-invasiveness, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neuroblastoma, neuroectodermal-tumors, nose-neoplasms, paranasal-sinus-neoplasms, sarcoma, skull-base-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Olfactory Neuroblastoma, and have been seen in publications frequently: Brain Development, Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Differentiation, Cell Proliferation, Coagulation, Excretion, Hormone Secretion, Localization, Mitosis, Mrna Splicing, Oncogenesis, Ossification, Pathogenesis, Pigmentation, Reverse Transcription, Secretion, Vasopressin Secretion

Quite a number of genes have been found to play important roles in Olfactory Neuroblastoma, such as ACAT1, AVP, CD99, CSF2, DES, ENO1, ENO2, EWSR1, GFAP, LAMC2, MUC1, POMC, POMT1, SLC25A5, SS18L1, SST, SYP, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.